Cantor Fitzgerald Issues Positive Outlook for BBIO Earnings
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) – Equities researchers at Cantor Fitzgerald boosted their FY2025 EPS estimates for shares of BridgeBio Pharma in a research report issued on Wednesday, April 30th. Cantor Fitzgerald analyst J. Schimmer now anticipates that the company will earn ($3.93) per share for the year, up from their prior forecast […]
BridgeBio Pharma, Inc. (NASDAQ:BBIO – Free Report) – Equities researchers at Cantor Fitzgerald boosted their FY2025 EPS estimates for shares of BridgeBio Pharma in a research report issued on Wednesday, April 30th. Cantor Fitzgerald analyst J. Schimmer now anticipates that the company will earn ($3.93) per share for the year, up from their prior forecast […]
